Richard Scranton
2017
In 2017, Richard Scranton earned a total compensation of $1.7M as Chief Scientific Officer at Pacira Pharmaceuticals.
Compensation breakdown
| Bonus | $150,000 |
|---|---|
| Option Awards | $770,418 |
| Salary | $378,462 |
| Stock Awards | $386,750 |
| Other | $966 |
| Total | $1,686,596 |
Scranton received $770.4K in option awards, accounting for 46% of the total pay in 2017.
Scranton also received $150K in bonus, $378.5K in salary, $386.8K in stock awards and $966 in other compensation.
Rankings
In 2017, Richard Scranton's compensation ranked 6,364th out of 14,666 executives tracked by ExecPay. In other words, Scranton earned more than 56.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,364 out of 14,666 | 57th |
Division Manufacturing | 2,345 out of 5,772 | 59th |
Major group Chemicals And Allied Products | 743 out of 2,075 | 64th |
Industry group Drugs | 575 out of 1,731 | 67th |
Industry Pharmaceutical Preparations | 454 out of 1,333 | 66th |
Source: SEC filing on April 27, 2018.
Scranton's colleagues
We found four more compensation records of executives who worked with Richard Scranton at Pacira Pharmaceuticals in 2017.